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Activation of immunocompetent cells in the peritoneum of patients
treated with CAPD. Chemiluminescence and flow cytometry, employing
a number of monoclonal antibodies, was used to investigate activation
of immunocompetent cells in the blood and peritoneum of patients
treated with CAPD. Increased expression of H LA-DR and RFD7, both
markers of macrophage maturation, was observed on peritoneal mac-
rophages, 78% and 33.5% cells positive, when compared to blood
monocytes, which were 46% and 5.3%, respectively (P < 0.001).
Macrophage chemiluminescent response to opsonized zymosan was
greater than that of circulating blood monocytes in CAPD patients,
whereas the inverse was true for normal controls. Enhanced expression
of IL-2 receptor and surface lgG by peritoneal macrophages were
24.9% and 65.3% cells positive compared with monocytes, 5.7% and
12.3% (P < 0.01), and also suggests their activation. There was a
marked increase in the HLA-DR expression by peritoneal lymphocytes
from CAPD patients (32% cells positive) compared with those from
CAPD blood (13.8%), normal blood (11.3%) and normal peritoneal fluid
(14.5%), P < 0.001. This was partially accounted for by increased
numbers of B cells (18%) and activated T cells bearing HLA-DR. TFR
and IL-2 receptor expression by CAPD peritoneal lymphocytes was
similar to that of blood lymphocytes, implying the lack of an organized
immune response within the peritoneum. Taken together, these results
suggest that peritoneal macrophages from CAPD treated patients have
features of maturation and activation, while changes in the lymphocyte
populations are compatable with the actions of IL-I, indicating activity
of the cellular immune system within the peritoneum.
Historically the murine peritoneum has been a major source
of cells for investigators of the monocyte/macrophage lineage.
Only since the introduction of continuous ambulatory perito-
neal dialysis (CAPD) have these cells in the human peritoneum
come under scrutiny. It is likely that they play an important part
in the host defence mechanisms of the peritoneum, primarily
through their ability to phagocytose and kill bacteria [1, 2].
However, it has been suggested that they may, by being in a
constantly activated state, be partially responsible for the
progressive fibrosis and loss of ultrafiltration capacity of the
peritoneal membrane [3].
Evidence that dialystate-elicited peritoneal macrophages
(CAPD-PMØ) represent an activated cell population is their
enhanced respiratory burst activity [2], morphology of acid-
peroxidase staining [4] and the presence of bioassayable inter-
leukin I (IL-I) in dialysate effluent [5]. However, it has also
been reported that CAPD-PM have reduced expression of
HLA-DR antigen on their surface and morphological features of
immature cells resembling blood monocytes (MON), possibly
representing an increased turnover of these cells due to con-
stant shedding into dialysate [6]. Many of the features of
'activated' macrophages, such as reduced acid peroxidase
staining and enhanced IL-I production, are also those of
circulating monocytes [7]. The problem, therefore, is whether
CAPD-PMØ represent an immature monocyte-like population,
mature resting macrophages or a form of activated cell capable
of sustaining a prolonged immunological assault on the perito-
neum.
In an attempt to answer this question, CAPD-PM were
examined for markers of maturity (expression of HLA-DR and
RFD7), proliferation (transferrin receptor, TFR), and activation
(interleukin-2 receptor, IL-2R, cell surface IgG and phagocytic
activity). In addition, to test the hypothesis that these cells
produce significant quantities of IL-l in vivo, peritoneal lym-
phocyte populations were examined for evidence of activation
(HLA-DR, TFR and IL-2R expression) and their I and B cell
phenotypes.
Methods
Cell populations
Peripheral blood monocytes (MON) and lymphocytes (LY)
were obtained from normal controls and peritonitis-free CAPD
patients by separation through Ficoll-Hypaque. The mononu-
clear layer was removed and washed (x 2) in HESS prior to
staining. Peritoneal cell populations were obtained from normal
women via a laparoscope while they were undergoing steriliza-
tion and peritonitis-free CAPD patients by centrifugation of the
overnight dialysate exchange. Cells were also obtained from the
peritoneum by lavage at the time of insertion of the peritoneal
catheter. Whole cell populations were washed following the
removal of contaminating red cells by lysis with Iris-buffered
ammonium chloride at 20°C. Cell viability was always >95% as
judged by Trypan-blue exclusion.
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Monoclonal antibodies (Mcab)
HLA-DR. Class H expression was assessed using a direct
fluorescein-conjugated mouse Mcab against the HLA-DR sur-
face antigen (Becton Dickinson). Preliminary studies confirmed
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that in vitro matured monocytes increased their expression of
HLA-DR using this Mcab.
RFD7. This Mcab is a marker for mature tissue macrophages
purchased from the Department of Immunology, The Royal
Free Hospital (London, UK). It is absent on circulating mono-
cytes, non-phagocytic antigen presenting cells and epitheliod
cells [81. It is present on mature phagocytic macrophages which
stain positively for acid phosphatase, such as alveolar or
peritoneal macrophages (confirmed in this laboratory, where
expression on peritoneal macrophages was >90%).
Transferrin receptor (TFR). A direct fluorescein-conjugated
mouse Mcab against the TFR (OKT9, Becton Dickenson) was
used to assess cell proliferation. Preliminary experiments dem-
onstrated a marked increase in TFR on Con-A stimulated
lymphocytes, and a progressive increase in TFR expression by
in vitro matured macrophages.
Interleukin-2 receptor (IL-2R). This was assessed using a
mouse monoclonal directed against the Tac antigen (from Dr. T.
Waldmann, National Institute of Health, Bethesda, Maryland,
USA) and was demonstrated to have strong positivity on Con-A
stimulated lymphocytes.
Surface IgG. A directly fluorescein conjugated Mcab (Sero-
tec) was used to assess CAPD-MON/PM surface IgG, an
indirect measure of the number of Fc receptors.
T and B cell markers. A mouse Mcab directed against CD2
(RFT1 I, IgG) was used as a pan-T cell marker and against CD2O
(RFB7, 1gM) as a pan-B cell marker (from the Department of
Immunology, The Royal Free Hospital, London, UK).
Procedure for labelling cells
Cells were resuspended in volumes of 100 pi containing
approximately l0 cells. Incubation with Mcab was carried out
for 40 minutes at room temperature with occasional mixing.
Directly fluorescein conjugated Mcab (HLA-DR, TFR, IgG)
was added in volumes of 20 pJ and a directly conjugated
irrelevant Mcab (Becton Dickinson) used as control. Other
Mcab were added in 10 p1 volumes and following incubation
and washing, 10 p1 of fluorescein-conjugated goat anti-mouse Ig
Mcab (Becton Dickinson) was added as a second stage, the
latter used alone acting as control. Double fluorescence, to
detect the presence of HLA-DR on T cells was achieved in
three stages: firstly by labelling with RFTI 1, secondly with
phycoerythrin-conjugated rabbit-anti-mouse IgG Fab' to give
red fluorescence (Serotec), and thirdly, following a blocking
stage using 5% mouse serum, the directly fluorescein (green)
conjugated HLA-DR.
Following labelling, cells were resuspended in PBS with 1.6%
formaldehyde and stored at 4°C prior to cytometry.
Flow fluorocytometry
This was performed using an Ortho Diagnostics FACS 1245.
Cell populations were analyzed according to their forward and
90 degree scatter properties. In all cases two main populations
were identified (Fig. 1) representing lymphocytes and mono-
cytes/macrophages. These populations were gated separately
and the mean and percentage of positive fluorescence over
control calculated.
MONIPMØ phagocytosis of opsonized zymosan
The phagocytic respiratory burst to zymosan opsonized with
pooled human serum was assessed by chemiluminescence.
Then, l0 cells were added to 2 mg of opsonized zymosan
suspended in HBSS, in the presence of lucigenin (0.001 M)
acting as a luminescent probe (final volume I ml). Phagocytic
activity was taken to be proportional to the peak luminescence
over the subsequent 30 minutes (mean of duplicate samples),
and was corrected for the absolute number of MON/PMØ
present using data obtained from cell cytometry.
Statistics
A non-parametric statistic (Mann-Whitney) was used through-
out for testing significance of paired (IL-2R, surface IgG) and
unpaired data.
Results
Cell morphology using flow cytometry
The crude numbers of cells obtained from the dialysate of
CAPD patients was highly variable. The absolute number from
an overnight effluent was usually of the order of 2 mfflion cells,
ranging between 0.5 and 12 million. The relative contribution of
macrophages versus lymphocytes was assessed by their mor-
phology on flow cytometry, and is summarized in Table 1 along
with data from peritoneal and blood mononuclear populations
in normal controls and CAPD patients. In almost all cases there
was no significant population of neutrophils identifiable, and
when present it was less than 5% of the total number.
Fig. 1. Flow cytometry of cell populations in blood (mononuclear
fraction) and peritoneal fluid from normal individuals (top panels) and
CAPD patients. Forward versus 90 degree scatter describes two main
populations in each case (encircled) representing lymphocytes, smaller
with less scatter, and monocytes/macrophages.
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Source
Macrophages/monocytes Lympho-
cytes
mean (%)Mean % Range SEM__-
Con-blood 17 7.4—36.1 2.8 82
N = 12
Con-perit 52 18.7—86.7 12.1 47N=6
CAPD-blood 33 5.6—50.2 4.1 66
N= II
CAPD-perit 40 5.7—91.4 5.5 57N = 24
SEM, standard
In normal controls macrophages represented a significantly
higher percentage of the peritoneal cell population (52%)when
compared to monocytes in the mononuclear fraction of normal
blood (17%), P = 0.0065. In CAPD patients the small difference
in this percentage of monocytes in the blood (33%) and macro-
phages in the peritoneum (40%) was not significant (P =0.48).
This was due both to a reduction in the absolute number of
blood lymphocytes and an increase in the relative number of
peritoneal lymphocytes in CAPD patients.
The large range in the relative number of peritoneal macro-
phages observed both in CAPD patients and normal controls
demonstrates the high degree of individual variation in perito-
neal cell populations.
Macrophage markers and phagocytic activity
HLA-DR expression. This is depicted in Figure 2. HLA-DR
expression by CON-PM, 91.6% cells positive, was higher
when compared to CON-MON. 81.3% (P = 0.008). This differ-
ential was also seen in CAPD patients where 78.2% of CAPD-
PMØ and 46.9% CAPD-MON were positive (P = 0.007).
HLA-DR expression on both CAPD-PM and CAPD-MON
depressed when compared with normal controls (P = 0.015).
Expression of macrophage marker RFD7. This is summa-
rized for blood monocytes (CAPD-MON) and peritoneal mac-
rophages (CAPD-MØ) from CAPD patients in Table 2. The
percentage of RFD7 positive cells was higher for peritoneal
macrophages than for circulating monocytes, P < 0.001. Mono-
cyte expression was essentially negative, (that is, <10%) as was
seen in normal controls. Peritoneal macrophage expression was
never as strongly positive as seen in normals (Methods).
Monocyte/macrophage response to opsonized zymosan. This
is also summarised in Table 2. The respiratory burst to op-
sonized zymosan, as measured by chemiluminscence, was
greater for peritoneal macrophages (CAPD-PMØ) than for
circulating monocytes (CAPD-MON) in CAPD patients. This is
the inverse to that observed in normal controls, although the
latter difference did not reach statistical significance.
There was a strong correlation between dialysate-elicited
peritoneal macrophage (CAPD-PMØ) expression of RFD7 and
chemiluminescence, r = 0.88, P < 0.01), suggesting that this
Mcab recognizes some aspect of the phagocytic granules or
mechanism in mature macrophages.
Transferrin receptor. Neither PM9. nor MON from normals
or CAPD patients showed significant positivity for this surface
RFD
N
7 % cells positive
Mean
Chemiluminescence
mV/JO5 cells
N Mean
CAPD-PMØ
CAPD-MON
Con-PMØ
Con-MON
15
7
335
5.3
3.9
2.3
18
7
5
8
319b
194b
14.6
23.6
4.6
4.2
5.6
4.36
marker. There was a small increase in fluorescence of the whole
cell population in each case, suggesting the presence of TFR in
low quantities, but this did not differ between the four groups.
Cells were also stained with pyridium iodide for their DNA
content which confirmed single non-proliferating populations.
!nterleukin-2 receptor and surface IgG. CAPD-PMØ were
consistantly more positive for the IL-2 receptor than circulating
monocytes from the same individuals (Table 3). In contrast,
IL-2R expression by peritoneal macrophages obtained at the
time of catheter insertion did not express this marker. There
was also enhanced expression of surface IgG on CAPD-PM
when compared with CAPD-MON (Table 3).
Lymphocyte surface markers and TIB cell phenotype
HLA-DR expression. Peritoneal lymphocyte populations
(Fig. 3) derived from CAPD patients expressed more HLA-DR,
Table 1. Cell morphology by flow cytometry: Relative numbers of
macrophages/monocytes and lymphocytes
P < 0.008 P< 0.007
Abbreviations are: Con, control; pent, peritoneal;
error of mean.
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Fig. 2. HLA-DR expression (as percentage of total) by monocytesl
macrophages from blood and peritoneal fluid in normal controls and
patients on CAPD.
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Table 3.
IL-2R % cells positive
Surface lgG %
positive
cells
N Mean N Mean
CAPD-PMØ
CAPD-MON
CAPD-PMØ
pre-dialysis
5 24.90 3.8
5 5.7k 2.9
5 3.8 2.7
5
5
65.3
12.3
4.5
2.3
a P < 0.01
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FIg. 4. Transferrin receptor expression (as percentage of total) by
lymphocytes from blood and peritoneal fluid in normal controls and
patients on CAPD.
HLA-DR. Results are summarized in Figure 5 and compared
with those obtained using the same markers on peripheral
blood. Dialysate T and B cell populations were highly hetero-
geneous with a relative reduction in T cells (mean 60% vs. 82%)
and increase in B cells (mean 18% vs. 7.5%), P <0.01, although
this was not enough to account for the observed HLA-DR
expression. Using double fluorescence (Fig. 6, legend) it was
possible to show that HLA-DR was also being expressed on T
cells.
Markers ofcell activation and peritonitis rates
This final experimental section is an attempt to put some of
the earlier data on activation of immunocompetent cells within
the peritoneum into the context of individual peritonitis rates.
Only four measures of cell activation/maturity were studied in
sufficient numbers of patients to make analysis meaningful:
macrophage expression of RFD7, chemiluminescence, macro-
phage HLA-DR and lymphocyte HLA-DR expression. The
total number of patients studied (N 26) were divided into
three main groups: those with a clearly low peritonitis rate
followed up for long enough to ensure they were having less
than one episode per year, those with a high rate (in excess of
two episodes per year) and an intermediate group which could
potentially fall into the low rate group if followed up for longer.
All patients included in this cross-sectional analysis were on
CAPD (either retrospectively or prospectively) for a minimum
of one year (mean 23.5 months).
The characteristics of high, medium, low rate groups are
Blood Pent. Blood Pent.
(N = 8) (N = 6) (N 9) (N = 20)
Fig. 3. HLA-DR expression (as a percentage of total) by lymphocytes
from blood and periwneal fluid in normal controls and patients on
CAPD.
32% cells positive, than those from blood, 13.9%, normal
peritoneum, 14.5% and normal blood, 11.3%, (P = 0.001).
Transferrin and interleukin-2 receptor expression. TFR
expression is summarized in Figure 4. There appears to be a
reduction in expression of this receptor in the normal perito-
neum, which is not seen in CAPD patients. There was no
significant difference between the IL-2R on CAPD blood (4.8%
cells positive, N = 5) and peritoneal lymphocyte populations
(4.7% positive, N = 5).
T and B cell phenotypes. In view of the disproportionate
increase of HLA-DR expression when compared to other
markers of lymphocyte activation, dialysate populations were
examined for their T and B cell phenotypes, as B cell expresses
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Fig. S. T and B lymphocyte phenotypes in blood (open symbols) and
peritoneal (closed symbols) populations.
summarized in Table 4. There is no significant difference
between the three groups in age, sex ratio or plasma creatinine
level.
Expression ofmarkers by different groups
Macrophage chemiluminescence, RFD7, HLA-DR and lym-
phocyte HLA-DR expression in patients with low, medium and
high peritonitis rates are summarized in Figure 7. There is a
significantly higher expression of RFD7 (P = 0.01) and chemi-
luminescent response to opsonized zymosan (P = 0.01) in
patients with a low incidence of peritonitis when compared to
the high incidence group. Both of these parameters appear to be
markers of phagocytic potential, suggesting that phagocytic
function in these patients is better preserved or even enhanced
in the peritoneum. Although there was a trend towards greater
macrophage expression of HLA-DR in the low peritonitis
group, this was not significant. Expression of HLA-DR by
lymphocytes in the high peritonitis group was significantly less
than in either of the other groups (high vs. low P = 0.03, high
vs. medium P = 0.016), providing further evidence that the
peritoneal cellular immune system in these patients is de-
pressed.
Discussion
In an attempt to clarify the status of peritoneal macrophages
derived from CAPD patients, cells obtained from dialysate
effluent were examined for their phagocytic function and a
variety of surface markers. These cell populations were com-
pared with their counterparts in peripheral blood and the
normal peritoneum. It remains an assumption of this work that
the cells obtained in this way are representative of the cellular
immune system as a whole within the pentoneum.
Both macrophages and lymphocytes were found as the prin-
cipal cell types within the peritoneum, although the relative
numbers of these two varied enormously between patients. It is
a significant finding by the methods used in this study that
peritoneal macrophages represented just 52% of cells in the
normal peritoneum and even fewer, 40%, in the dialyzed
patient. Previous authors have tended to concentrate on the
peritoneal macrophage, finding it to account for between 75 and
95% of cells elicited, the remainder being neutrophils [1,6,9].
However Peterson [2] did report a relative reduction of macro-
phages in the dialyzed peritoneum, and others have drawn
attention to the peritoneal lymphocyte population. Cichoki [10]
demonstrated that in some CAPD patients the predominant cell
type was the lymphocyte, and in the majority the proportion of
lymphocytes and macrophages was roughly equal. Kubicka
[11], using both cell morphology and fluorescein-labelled mono-
clonal antibodies to examine the peritoneal cell populations in
normal individuals undergoing elective cholecystectomy, found
on average that 45% of cells were macrophages. Again the rest
appeared to be lymphocytes, although there was a large varia-
tion between individuals. Others examining dialysate elicited
cells by fluorocytometric methods similar to those used here
have found a majority of lymphocytes in the dialyzed perito-
neum [12, 13]. While it is difficult to explain these different
findings, which are probably due to the various methodologies
used, it seems likely that the importance of peritoneal lympho-
cytes has been underestimated in the past.
The increase in HLA-DR expression observed on normal
peritoneal macrophages in this study is in keeping with the
suggestion that this is a marker of cell maturation. It is similar
to that demonstrated for alveolar macrophages from normal
lungs [7, 14—16], and can be reproduced on monocytes matured
to macrophages in vitro. There was reduced HLA-DR expres-
sion by both monocytes and macrophages from CAPD patients
when compared to controls, as reported by Goldstein et al [6],
perhaps reflecting a generalized disturbance in these patients.
However, there was still a clear increase in HLA-DR expres-
sion by the peritoneal macrophages, indicating that a degree of
cell maturation occurs.
RFD7 is a marker of mature tissue macrophages with phago-
cytic potential [8], and this is supported by the finding that its
expression by CAPD-PMØ correlated closely with respiratory
burst activity. While its presence on dialysate elicited macro-
phages supports the idea that these cells have undergone
maturation, the mean number of positive cells was only 33%,
suggesting curtailment of this process, perhaps due to rapid cell
turnover as suggested by Goldstein et al [6]. The enhanced
chemiluminescent response by CAPD-PM compared to
CAPD-MON is in contrast to the small reduction seen in the
normal controls. This observation, similar to that made by
Peterson et al [2], is in keeping with activation of these cells.
The failure of peritoneal macrophages from either normals or
CAPD patients to express significant amounts of TFR was
unexpected. Blood monocytes matured in vitro to macrophages
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Fig. 6. Double fluorescence: In the left panel
the lymphocytes are from normal peripheral
blood, the right from dialysate fluid. The Y-
axis (green fluorescence) represents HLA-DR
expression, the X-axis (red fluorescence) T
cells. Region 2 on the left contains few cells
(<3%), whereas on the right 32% of the
lymphocytes fall into this region.
Table 4. Patient groups
Low Medium High
Peritonitis rate <1/year 1—2/year >2/year
Number 10 10 6
Age 47,4 (25—68) 55.6 (28—65) 48.8 (24—62)
M:F sex ratio 5:5 5:5 3:3
Plasma creatinine 850 774 900
Peritonitis data
Episodes: total 9 17 32
:per patient 1.1 1.7 5.3
Months on
dialysis
mean 30.2 16.7 24
Rate: (1/months) 1/33.5 1/9.8 1/4.5
expressed this marker, a finding also reported recently by
others who, in addition, were able to demonstrate its presence
on alveolar macrophages [17]. It is known that alveolar macro-
phages are capable of proliferation [181, a process for which the
TFR is a marker on many cell types [19, 20]. Further evidence
that the peritoneal macrophage is not a proliferating cell comes
from the use of pyridium iodide to stain nuclear DNA which
failed to show dividing cells. Whereas it has been suggested that
alveolar macrophages may be in part a self-supporting popula-
tion [181, this would not appear to be the case for macrophages
in the dialyzed (or normal) peritoneum, necessitating the con-
stant influx of immature monocytes to maintain numbers.
The increased expression of IL-2R by CAPD-PMØ, not seen
in cells obtained prior to the commencement of dialysis, is
likely to represent activation of these cells. Although not
present on normal peritoneal macrophages [11], it is now known
that macrophages can express the IL-2R when activated by a
variety of cytokines, most notably interferon-gamma [211, and it
is seen on alveolar macrophages from patients with active
sarcoidosis. It is of interest that while normal alveolar macro-
phages are unable to present antigen to resting T cells [22],
those from patients with sarcoidosis can, raising the possibility
that peritoneal macrophages from CAPD patients may be able
to perform this function. The increase in CAPD-PMØ cell
surface IgG also suggests their activation, as it is an indirect
measure of the Fc receptor present on monocytes/macro-
phages. Monocytes activated with interferon-gamma show a
marked increase in both number and affinity of Fc receptors
[23—25] with subsequent increased binding of surface IgG and
enhanced phagocytic function.
As a further indicator of macrophage activation the hypoth-
esis that these cells produce significant quantities of IL- 1 in vivo
was tested by examining for its effect on peritoneal lymphocyte
populations. Of the plethora of actions exhibited by this cyto-
kine, the activation and proliferation of T and B cells were
assessed.
The highly significant increase in HLA-DR expression by
peritoneal lymphocytes when compared with blood and normal
peritoneum suggests that these cells represent an altered pop-
ulation. It was possible to demonstrate increased heterogeneity
in the phenotype of peritoneal lymphocytes, increased numbers
of B cells and expression of HLA-DR by T cells, in keeping
with their activation. Similar proportions and heterogeneity in
peritoneal T and B lymphocyte populations have been found by
Chandrasekeran et al [121. Further corroboration of these
findings, including HLA-DR expression by T cells using flow
cytometric methods similar to that used here have been re-
ported by Gelato et al [13]. While these findings are only
indirect measures of IL-l activity [26, 27], they do suggest that
there is increased secretion of this cytokine that is having
physiological effects within the peritoneum.
The lack of peritoneal lymphocyte expression of TFR and
IL-2R would suggest that despite some features of activation,
there is no evidence of intraperitoneal proliferation or clonal
expansion of these cells. It seems unlikely, therefore, that there
is any form of organized immune response within the clinically
uninfected peritoneum.
Finally, there does appear to be an inverse relationship
between patients' peritonitis rates and several markers of
immunological activity within the peritoneum. There seemed to
be a graded association between peritonitis incidence and
markers of macrophage activation, in particular those associ-
ated with phagocytic function. The expression of HLA-DR by
666 Davies et a!: Activation of immunocompelent cells
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Davies et a!: Activation of immunocompetent cells 667
Baxter-HealthCare and a grant from the Special Trustees, United
Medical & Dental Schools of Guy's and St Thomas's Hospitals,
London, United Kingdom.
Reprints to Dr. Simon Davies, Renal Unit, Guy's Hospital, London
SEJ 9RT, United Kingdom.
.
• •
1. VERBRUGH HA, KEANE WF, HOIDAL JR, FREIBERG MR, ELLIOTT
GR, PETERSON PK: Peritoneal macrophages and opsonins: Anti-30 bacterial defence in patients undergoing chronic peritoneal dialysis.•
JlnfectDis 147:1018—1027, 1983
• 2. PETERSON PK, GAZIANO E, SUH HJ, DEVALON M, PETERSON L,
• KEANE WF: Antimicrobial activities of dialysate-elicited and resi-
• dent human peritoneal macrophages. InfectImmuno! 49(l):212—
218, 1985
3. SHALDON S: Is CAPD a second class treatment? in Proceedings of
70 the IlIrd Internal Symposium on Peritoneal Dialysis, edited by
MAHER JF, WINCHESTER JF, Washington DC, NewYork, Field &
• Rich, 1986, pp. 304—306
• 4. Bos HJ, VAN BRONSWIJK H, HELMERHORST TJM, OE PL, HOEF-
SMIT ECM, BEELEN RHJ: Distinct subpopulations of elicited
human macrophages in peritoneal dialysis patients and women
50 undergoing laparoscopy: A study on peroxidatic activity. JLeuko-
cyteBiol43:182—178, 1988
5. SHALDON S, KOCH KM, QUELLHORST E, DINARELLO CA: Patho-
genesis of sclerosing peritonitis. Trans Am Soc Art if Organs 32:179,
• 1986
• 6. GOLDSTEIN CS, BOMALASKI JS, ZURIER RB, NEILSON EG, Dou-
30 GLAS SD: Analysis of peritoneal macrophages in continuous ambu-
• latory peritoneal dialysis. Kidney mt 26:733—740, 1984
7. WEISSLER JC, LYONS CR, LIP5C0MB MF, TOEWS GB: Human
pulmonary macrophages. Functional comparison of cells obtained
• from whole lung and by bronchoalveolar lavage. Am Rev Respir Dis
133:473—477, 1986
I 8. JANOSSY G, BOFILL M, POULTER LW, RAWLINGS E, BURFORDGD, NAVARRETE C, ZIEGLER A, KELEMEN E: Separate ontogeny
Low Med High of two macrophage-like accessory cell populations in the human
fetus. Jlmmunol 136:4354—4361, 1986
9. KEANE WF, COMPTY CM, VERBRUGH HA, PETERSON PK: Opsonic
deficiency of peritoneal dialysis effluent in continuous ambulatory
peritoneal dialysis. Kidney mt 25:538—543, 1984
10. CICH0CKI T, HANICIU Z, SULOWICZ W, SMOLENSKI 0, KOPEC J,
ZEMBALA M: Output of peritoneal cells into peritoneal dialysate.
Cytochemical and functional studies. Nephron 35:175—182, 1983
11. KUBICKA U, HALDYK Z, WIERZBICKI, ORKISZEWSKA A, OLSZE-
wSKI WL: In vitro assessment of human peritoneal cells. Periton
Dial Bull 7(2):S43, 1987
12. CHANDRASEKARAN B, SCHULTZ EF, DEBARI VA, RONQUILLO CT,
NEEDLE MA: Surface marker characterization of peritoneal dialy-
sis patients' intraperitoneal leukocytes by monoclonal antibodies,
in Frontiers in Peritoneal Dialysis, edited by MAHER JF, WINCHES-
TER JF, New York, Field, Rich and Assoc., 1986, pp. 583—585
13. GALAT0 R, SEVESO M, BRANDO B, SOMMARUGA E, MINETTI L:
Flow cytometnc characterisation of immunocompetent cells of
peritoneal effluent. Nephrol Dial Transplant 2(5):453, 1987
14. COSTABEL U, BROSS KJ, ANDREESEN R, MATTHYS H: HLA-DR
antigenson human macrophages from bronchoalveolar lavage fluid.
Thorax 41(4):261—265, 1986
15. GANT VA, HAMBLIN AS: Human bronchoalveolar macrophage
heterogeneity demonstrated by histochemistry, surface markers
and phagocytosis. Clin Exp Immunol 60:539—545, 1985
16. CLERICI N, REBOIRAS S, FIERRO C, LEYVA-COBIAN F: Expression
of La like (HLA-DR) antigens on human alveolar macrophages. Clin
Exp Immunol 58:388—394, 1984
17. HIRATA T, BITTERMAN PB, MORNEX JF, CRYSTAL RG: Expression
of the transferrin receptor gene during the process of mononuclear
phagocyte maturation. J Immunol l36(4):1339—l345, 1986
18. GOLDE DW, BYERS LA, FINLEY TN: Proliferative capacity of the
human alveolar macrophage. Nature 247:373, 1974
19. HAYNES BF, HEMLER M, COTNER T, MANN DL, EISENBARTH GS,
70
•
50 •
30
90
60
S
I
•
C
8
U,U,
E
E
$IS.
•
References
+
8
N0U.
+
8
0
I
S
•
•
I
•
I00
80
60
•
.•
8
.
•
0
I
I
•
I
Low Med High
Fig. 7. Expression of the macrophage marker RFD7 (left upper panel),
macrophage and lymphocyte HLA-DR (lower panels) and the macro-
phage chemiluminescent response to opsonized zymosan (right upper
panel) by patients grouped according to their peritonitis rate, LOW =
lowest rate, less than one episode/year, MED = medium rate and
HIGH = highest, more than two episodes/year.
lymphocytes, a crude but inclusive marker of activation of
these cells was depressed in those with high peritonitis rates.
However, it is not possible to invoke cause or effect, as these
data are cross-sectional rather than prospective, and it may well
be that frequent peritonitis has a profound immunosuppressive
effect on the peritoneum in patients who are often chronically ill
and undernourished. Still, the association of good phagocytic
function with extremely low peritonitis rates is suggestive of a
protective effect, and is in keeping with observations made by
Lamperi et a! [28]. Whether or not the cellular activation
suggested by this study, occurring in the clinically uninfected
patient is capable of causing long-term peritoneal damage
remains to be determined.
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